Mice were immunized twice at 2-week intervals with DCs pulsed with chaperone vaccines s.c. or with the chitosan-siRNA complex plus hsp110-gp100 vaccine. For intracellular IFN-γ staining, cells were treated with brefeldin A (5 μg/mL, BD GolgiPlug; BD Biosciences) for 3 h at 37 °C. In some cases, cells were stimulated with phorbol-12-myristate-13-acetate (PMA, 50 ng/mL) plus ionomycin (1 μg/mL). Cells were stained with anti-CD8 or CD90.1 antibodies, followed by fixation, permeabilization and staining with anti-IFN-γ antibodies (BD Biosciences). Cells were analyzed by gating on CD8+ or CD8+CD90.1+ T cells. To examine the frequency of IFN-γ-producing T cells, cells were stimulated with gp10025–33 peptide and subjected to ELISPOT analysis (25). An in vivo CTL assay was performed to determine the cytolytic activity of gp100-specific CTLs as we previously described (17).
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.